Tag: virtual biopsy market overview

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Virtual Biopsy Market Growth From $0.79 Billion In 2026 To $1.23 Billion By 2030 At A CAGR Of 11.7%

The virtual biopsy market has experienced substantial expansion in recent years. It is projected to expand from $0.71 billion in 2025 to $0.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historically, this growth can be ascribed to factors such as dependence on conventional biopsy methods, restricted capabilities of imaging technology, the escalating incidence of chronic illnesses, the development of hospital and diagnostic infrastructure, and the heightened need for precise cancer diagnoses.

The virtual biopsy market is projected for significant expansion in the coming years. Its valuation is set to reach $1.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.7%. This anticipated growth during the forecast period is fueled by several factors, including developments in imaging algorithms and AI analytics, the broadening of diagnostic applications in oncology and neurology, increasing use for cardiovascular and ophthalmological conditions, integration with personalized medicine strategies, and rising capital expenditure in research institutions and diagnostic facilities. Key trends anticipated within this period involve a greater embrace of non-invasive diagnostic methods, an escalating need for early disease identification, the combination of sophisticated imaging with predictive analytics, an extension of virtual biopsy utility across various therapeutic fields, and an intensified emphasis on patient comfort alongside quicker recovery.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=40822746&type=smp&name=Virtual%20Biopsy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Virtual Biopsy Market Expansion Drivers: What’s Shaping Future Growth?

The increasing incidence of cancer-related conditions is anticipated to drive the expansion of the virtual biopsy market in the future. Oncological disorders refer to diseases involving uncontrolled growth and dissemination of abnormal cells within the body. This growth in oncological disorders is largely attributable to evolving lifestyles, including unhealthy eating habits, lack of physical exercise, smoking, and heightened exposure to environmental contaminants. Virtual biopsy supports the detection and oversight of these conditions through non-invasive, immediate imaging data, lessening the necessity for conventional tissue biopsies and simultaneously boosting diagnostic precision and patient well-being. For example, in January 2023, the U.S.-based digital health research firm Rock Health stated that 1,958,310 new cancer cases are forecast in the U.S. for 2023, representing an increase from approximately 1.9 million new cases in 2022. Consequently, the growing occurrence of oncological disorders is a key factor propelling the expansion of the virtual biopsy market.

Virtual Biopsy Market Segmentation: How Does The Market Break Down By Category?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Virtual Biopsy Market Strategic Trends: What Defines The Next Growth Phase?

Leading companies within the virtual biopsy market are prioritizing the development of advanced technological solutions and obtaining crucial approvals, including for the magnetic resonance spectroscopy (MRS) platform, to boost non-invasive diagnostic precision and offer real-time analysis for prompt disease detection and personalized therapeutic strategies. Magnetic resonance spectroscopy (MRS) serves as a non-invasive imaging method that supports virtual biopsy by providing intricate molecular details of tissues, thereby facilitating accurate, real-time disease identification and ongoing surveillance without the necessity of invasive procedures. As an illustration, in November 2023, BrainSpec Inc., a US-based healthtech company, secured approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-driven BrainSpec platform. This innovation leverages sophisticated artificial intelligence (AI) analysis of MR spectroscopy data to measure brain metabolites like 2-hydroxyglutarate, allowing for non-invasive virtual biopsies to diagnose conditions such as gliomas, alzheimer’s, and multiple sclerosis. The system is designed for seamless integration with standard magnetic resonance imaging (MRI) scanners, automates data processing, and delivers results within minutes. It also utilizes a comprehensive reference database of brain chemistry to further refine diagnostic accuracy.

Virtual Biopsy Market Key Participants And Competitive Landscape

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

View The Full Virtual Biopsy Market Report:

https://thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Virtual Biopsy Market Geographic Analysis: Where Is Demand Accelerating Fastest?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Virtual Biopsy Market Compare Between 2026 And 2030?

The virtual biopsy market has seen significant expansion in recent years. This market is set to expand from $0.71 billion in 2025 to $0.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. The historical drivers for this growth include the reliance on traditional biopsy procedures, the existing limitations in imaging technology capabilities, the rising prevalence of chronic diseases, the expansion of hospital and diagnostic infrastructure, and the growing demand for accurate cancer diagnostics.

The virtual biopsy market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $1.23 billion, demonstrating a compound annual growth rate (CAGR) of 11.7%. This projected growth during the forecast period stems from factors such as progress in imaging algorithms and AI analytics, the broadening of diagnostic applications in oncology and neurology, greater acceptance in managing cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and heightened investment in research facilities and diagnostic centers. Key trends for this period encompass a rise in the use of non-invasive diagnostic methods, a growing imperative for early disease identification, the fusion of sophisticated imaging with predictive analytics, an broadening of virtual biopsy’s utility across numerous therapeutic domains, and an increasing emphasis on patient well-being and faster recuperation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Virtual Biopsy Market?

The increasing incidence of cancer-related conditions is anticipated to fuel the expansion of the virtual biopsy market in the future. Oncological disorders involve the uncontrolled proliferation and dissemination of atypical cells within the body. This surge in cancer cases is largely attributed to shifts in lifestyle, including inadequate nutrition, sedentary habits, smoking, and heightened exposure to environmental contaminants. Virtual biopsy plays a crucial role by improving the diagnosis and oversight of these disorders, offering non-invasive, immediate imaging data that lessens the necessity for conventional tissue biopsies while boosting precision and patient well-being. For example, a January 2023 report from Rock Health, a U.S.-based digital health research firm, indicated a projection of 1,958,310 new cancer cases in the U.S. for 2023, marking an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing occurrence of oncological disorders is propelling the development of the virtual biopsy market.

What Are The Main Segments Within The Virtual Biopsy Market Segment Structure?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Which Trends Are Shaping The Virtual Biopsy Market?

Major companies operating within the virtual biopsy market are prioritizing the development of technologically advanced solutions and obtaining regulatory approvals, such as for the magnetic resonance spectroscopy (MRS) platform, with the aim of improving non-invasive diagnostic precision and delivering real-time analysis for early disease detection and customized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that supports virtual biopsy by providing detailed molecular information about tissues, facilitating accurate, real-time disease identification and monitoring without the need for invasive interventions. As an illustration, in November 2023, BrainSpec Inc., a US-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-driven BrainSpec platform. This technology leverages advanced artificial intelligence (AI) analysis of MR spectroscopy data to measure brain metabolites such as 2-hydroxyglutarate, thereby enabling non-invasive virtual biopsies for the diagnosis of conditions like gliomas, Alzheimer’s, and multiple sclerosis. The system integrates effortlessly with conventional magnetic resonance imaging (MRI) scanners, automates data processing, and generates results in minutes. It further utilizes a reference database of brain chemistry to boost diagnostic accuracy.

Who Are The Companies Participating In The Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

Get The Full Virtual Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Region Is The Largest In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Virtual Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Virtual Biopsy Market In 2026 And What Value Is Projected For 2030?

The virtual biopsy market has experienced rapid expansion in recent years. It is projected to increase from $0.71 billion in 2025 to $0.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. The market’s past growth can be attributed to factors such as continued reliance on traditional biopsy procedures, limited imaging technology capabilities, the increasing prevalence of chronic diseases, the expansion of hospital and diagnostic infrastructure, and a rising demand for accurate cancer diagnostics.

The virtual biopsy market is poised for significant expansion in the coming years, with projections indicating a rise to $1.23 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 11.7%. This anticipated growth stems from several factors, including ongoing advancements in imaging algorithms and AI analytics, the broadening of diagnostic applications in oncology and neurology, greater uptake in treating cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and increasing investments directed towards research institutions and diagnostic facilities. Key developments anticipated during this period encompass a wider acceptance of non-invasive diagnostic methods, a heightened need for early disease identification, the fusion of sophisticated imaging techniques with predictive analytics, an extension of virtual biopsy’s utility across various therapeutic fields, and an increased emphasis on patient well-being and faster recuperation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

What Drivers Are Influencing The Virtual Biopsy Market?

The increasing occurrence of cancer-related conditions is anticipated to boost the expansion of the virtual biopsy market in the future. Oncological disorders encompass various cancer types where atypical cells proliferate and disseminate throughout the body. The uptick in these disorders is largely attributable to evolving lifestyle habits, including inadequate nutrition, sedentary routines, smoking, and greater exposure to environmental contaminants. Virtual biopsy technology supports the diagnosis and oversight of oncological conditions by offering non-invasive, immediate imaging data, thereby decreasing the necessity for conventional tissue sampling while simultaneously elevating diagnostic precision and patient well-being. For example, in January 2023, a report from Rock Health, a U.S.-based digital health research firm, indicated a projection of 1,958,310 new cancer cases in the U.S. for 2023, representing an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing incidence of oncological disorders is a key factor propelling the virtual biopsy market forward.

What Are The Key Segments Of The Virtual Biopsy Market?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

What Key Trends Are Influencing The Development Of The Virtual Biopsy Market?

Major enterprises operating within the virtual biopsy market are concentrating on creating technologically sophisticated solutions and securing necessary approvals, such as for the magnetic resonance spectroscopy (MRS) platform. This effort aims to elevate non-invasive diagnostic precision and offer real-time analysis for the prompt identification of diseases and tailored therapeutic approaches. Magnetic resonance spectroscopy (MRS) serves as a non-invasive imaging method that supports virtual biopsy by supplying comprehensive molecular data about tissues, thereby facilitating accurate, real-time disease identification and ongoing monitoring without requiring intrusive procedures. For example, in November 2023, the U.S. Food and Drug Administration (FDA) granted approval to the artificial intelligence (AI)-driven BrainSpec platform, developed by BrainSpec Inc., a healthtech firm based in the US. This technology employs sophisticated artificial intelligence (AI) analysis of MR spectroscopy data to quantify brain metabolites, including 2-hydroxyglutarate, thereby enabling non-invasive virtual biopsies for diagnosing conditions such as gliomas, alzheimer’s, and multiple sclerosis. The system is designed to integrate smoothly with standard magnetic resonance imaging (MRI) scanners, automate data processing, and yield results in just minutes. Furthermore, it leverages a reference database of brain chemistry to enhance diagnostic accuracy.

Who Are The Leading Companies Operating In The Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

Read the full virtual biopsy market report here:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Virtual Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Virtual Biopsy Market be in 2030 compared with 2026?

The virtual biopsy market size has experienced significant growth in recent years. This market is projected to expand from $0.71 billion in 2025 to $0.79 billion in 2026, at a compound annual growth rate (CAGR) of 11.9%. The historical expansion of this market can be attributed to several factors, including reliance on traditional biopsy procedures, limited imaging technology capabilities, the increasing prevalence of chronic diseases, a growing hospital and diagnostic infrastructure, and a rising demand for accurate cancer diagnostics.

The virtual biopsy market size is poised for significant expansion over the coming years. By 2030, this market is projected to reach a value of $1.23 billion, demonstrating a compound annual growth rate (CAGR) of 11.7%. The anticipated growth during this period stems from several factors, including developments in imaging algorithms and AI analytics, broader applications in oncology and neurological diagnostics, increased use for cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and rising funding for research institutions and diagnostic facilities. Key trends foreseen over the forecast horizon encompass a greater embrace of non-invasive diagnostic methods, a heightened need for discovering diseases early, the merging of advanced imaging with predictive analytics, the broadening scope of virtual biopsy uses across diverse therapeutic fields, and an amplified emphasis on patient well-being and quicker recovery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

What Drivers Are Guiding Growth Patterns In The Virtual Biopsy Market?

The expanding occurrence of cancer-related conditions is anticipated to fuel the expansion of the virtual biopsy market moving forward. Oncological disorders are health issues tied to cancer, characterized by the uncontrolled proliferation and dissemination of atypical cells within the body. The surge in these conditions primarily stems from lifestyle shifts, including unhealthy eating, lack of physical activity, tobacco consumption, and greater exposure to environmental contaminants. Virtual biopsy aids in detecting and tracking oncological disorders by offering non-invasive, immediate imaging data, thereby diminishing the necessity for conventional tissue biopsies and simultaneously enhancing diagnostic precision and patient well-being. For example, in January 2023, Rock Health, a digital health research entity based in the U.S., reported a projection of 1,958,310 new cancer instances in the U.S. for 2023, marking an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing incidence of oncological disorders is propelling the growth of the virtual biopsy market.

Which Segments Are Driving Activity In The Virtual Biopsy Market?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

How Are New Market Trends Shaping The Landscape Of The Virtual Biopsy Market?

Leading companies within the virtual biopsy market are concentrating on the development of technologically advanced solutions and the acquisition of necessary approvals, such as for the magnetic resonance spectroscopy (MRS) platform, aiming to improve non-invasive diagnostic accuracy and deliver real-time analysis for the early detection of diseases and personalized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that aids virtual biopsy by offering comprehensive molecular information about tissues, which allows for precise, real-time identification and monitoring of diseases without requiring invasive procedures. For instance, in November 2023, BrainSpec Inc., a US-based healthtech company, obtained approval from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-driven BrainSpec platform. This technology employs advanced artificial intelligence (AI) analysis of MR spectroscopy data to quantify brain metabolites like 2-hydroxyglutarate, thereby facilitating non-invasive virtual biopsies for diagnosing conditions such as gliomas, Alzheimer’s, and multiple sclerosis. The system integrates effortlessly with standard magnetic resonance imaging (MRI) scanners, automates data processing, and produces results within minutes. It further utilizes a reference database of brain chemistry to enhance diagnostic precision.

Which Key Market Players Are Investing In Expansion And Innovation Within The Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Virtual Biopsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company

Virtual Clinical Trials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Virtual Biopsy Market Expected To Become By 2029 Compared With Its 2025 Level?

The valuation of the virtual biopsy sector has seen substantial recent expansion, projected to climb from its 2024 figure of $0.63 billion to $0.71 billion by 2025, indicating a compound annual growth rate (CAGR) of 11.4%. This historical upward trajectory is fundamentally driven by several key factors: a heightened need for diagnostic procedures that avoid surgical intervention, a stronger inclination towards identifying illnesses at their earliest stages, improvements in the efficacy of medical visualization software, enhanced ease and comfort for patients undergoing assessments, and the broader accessibility of remote healthcare solutions.

Anticipation is for swift expansion within the realm of virtual biopsy over the immediate future, projecting a market valuation reaching $1.11 billion by the year 2029, which signifies a compound annual growth rate (CAGR) of 11.8%. This surge throughout the projected timeframe is fundamentally driven by several key factors: an increased emphasis on healthcare solutions that offer greater cost-efficiency, a heightened commitment to proactive health monitoring strategies, the escalating requirement for customized medical treatments, a rising proclivity for non-invasive cancer interventions, and the ever-increasing significance placed upon oncology practices characterized by high accuracy. Furthermore, noteworthy developments shaping this period involve advancements in imaging sensor technology, the creation of combined biopsy methodologies, the incorporation of robotic systems to boost exactitude, novel approaches to identifying biomarkers without surgical intrusion, and the incorporation of visualization aids that process three-dimensional data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

Which Drivers Are Supporting Growth Of The Virtual Biopsy Market?

The escalating incidence of cancer-related illnesses is anticipated to fuel the expansion of the virtual biopsy sector in the near future. Cancer, characterized by the uncontrolled multiplication and dissemination of aberrant cells, represents significant health challenges, and its growing frequency is largely attributable to shifts in modern living, including suboptimal nutrition, sedentary habits, tobacco consumption, and greater contact with environmental toxins. Virtual biopsy technology substantially aids in the detection and tracking of these oncological conditions, offering non-invasive, immediate visual data that lessens reliance on conventional tissue sampling while simultaneously boosting precision and ensuring better patient outcomes. To illustrate this trend, data released in July 2024 by the Australian Institute of Health and Welfare, a governmental body in Australia, indicated that cancer diagnoses in the country climbed to 160,570 across the year 2022, signifying a jump of 3,789 from the 156,781 cases documented in 2021; consequently, this upward trend in cancer occurrences is serving as a key motivator for the expansion of the virtual biopsy market.

What Are The Segment Types Shaping The Virtual Biopsy Market?

The virtual biopsymarket covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Which Trends Are Impacting The Virtual Biopsy Market?

Leading entities within the virtual biopsy sector are concentrating efforts on engineering sophisticated technological capabilities and securing necessary regulatory clearances, exemplified by systems like the magnetic resonance spectroscopy (MRS) offering, with the objective of elevating the precision of non-invasive diagnoses and delivering immediate analytical feedback crucial for the early identification of ailments and tailoring patient therapies.MRS stands as a technique employing non-surgical imaging principles to augment virtual biopsy procedures by furnishing in-depth molecular data from biological tissues, thus permitting precise, immediate identification and tracking of diseases, circumventing the requirement for intrusive operations. Illustratively, in the eleventh month of 2023, the American health technology firm known as BrainSpec Inc. successfully obtained authorization from the United States Food and Drug Administration (FDA) for its platform, the BrainSpec, which incorporates artificial intelligence (AI). This particular innovation leverages sophisticated AI evaluation of MRS data to quantify neuro-metabolites like 2-hydroxyglutarate, thereby enabling non-penetrative virtual biopsies for diagnostic purposes across various pathologies including gliomas, Alzheimer’s disease, and multiple sclerosis. The framework is designed for smooth integration with conventional magnetic resonance imaging (MRI) equipment, automatically handles the data computation, and produces outcomes in mere minutes, further leveraging a repository of normal brain chemistry profiles to boost diagnostic reliability.

Which Leading Players Are Enhancing Their Virtual Biopsy Market Presence Worldwide?

Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Virtual Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2025, By The Business Research Company

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Biopsy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market 2025

https://www.thebusinessresearchcompany.com/report/biopsy-devices-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Virtual Biopsy Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

There has been rapid growth in the market size of virtual biopsies in recent years. Rising from a value of $0.63 billion in 2024, it is forecasted to increase to $0.71 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The growth during the historic period is linked to the escalating demand for non-invasive diagnostic techniques, a heightened preference for early detection of diseases, improving efficiency of medical imaging software, the rising comfort and convenience for patients, and the increase in the availability of telemedicine services._x000D_

_x000D_

In the next several years, the size of the virtual biopsy market is projected to grow rapidly, reaching $1.11 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%. This growth momentum during the forecast period is likely to be fuelled by factors such as a greater emphasis on cost-efficient healthcare solutions, increasing preventative healthcare initiatives, a surge in demand for customised medicine, a higher need for minimally invasive procedures in cancer treatments, and the rising relevance of precision oncology. Additionally, key trends for this period include the advancement in imaging sensors, the development of multimodal biopsy methods, the adoption of robotics for enhanced precision, advancement in non-invasive biomarker detection techniques, and the incorporation of three-dimensional (3D) visualisation instruments._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Virtual Biopsy Industry?#_x000D_

The increasing occurrence of cancer-related conditions is projected to fuel the expansion of the virtual biopsy market. Such health conditions involve abnormal cell proliferation and spread throughout the body, and their growing occurrence is mostly due to lifestyle alterations such as bad eating habits, lack of physical activity, tobacco consumption, and increased exposure to environmental pollutants. Virtual biopsies enhance cancer condition diagnosis and tracking by offering real-time, non-invasive imaging insights. These reduce the need for conventional tissue biopsies and heighten precision and patient safety. As an example, the Australian Institute of Health and Welfare, an agency run by the Australian government, reported that cancer diagnoses in Australia grew to 160,570 cases in 2022, a rise of 3,789 cases from 156,781 in 2021, in July 2024. Consequently, the escalating rate of cancer-related conditions is propelling the virtual biopsy market’s development._x000D_

_x000D_

#How Is the Virtual Biopsy Market Segmented?#_x000D_

The virtual biopsymarket covered in this report is segmented – _x000D_

_x000D_

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas_x000D_

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds_x000D_

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies_x000D_

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers_x000D_

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions_x000D_

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions_x000D_

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders_x000D_

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions_x000D_

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions_x000D_

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Virtual Biopsy Market Growth?#_x000D_

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Virtual Biopsy Industry?#_x000D_

Leading firms in the virtual biopsy market are concentrating on the production of technologically superior solutions and securing approvals like the magnetic resonance spectroscopy (MRS) platform. Their aim is to bolster non-intrusive diagnostic precision and offer real-time analysis for the early detection of diseases and tailored treatment options. Magnetic resonance spectroscopy (MRS), a non-intrusive imaging method that aids virtual biopsy, delivers comprehensive molecular data of tissues. This enables precise, instantaneous disease detection and tracking, eliminating the need for invasive approaches. For example, in November 2023, BrainSpec Inc., a healthtech enterprise based in the US, obtained U.S. Food and Drug Administration (FDA) authorization for its artificial intelligence (AI)-powered BrainSpec platform. This cutting-edge technology uses enhanced AI to parse MR spectroscopy data to measure brain metabolites like 2-hydroxyglutarate, aiding non-intrusive virtual biopsies for the diagnosis of ailments such as gliomas, Alzheimer’s, and multiple sclerosis. The system, which integrates smoothly with standard magnetic resonance imaging (MRI) scanners, automates data processing and delivers results within minutes. Additionally, it employs a reference database of brain chemistry to enhance diagnostic precision._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report_x000D_

_x000D_

#How Is the Virtual Biopsy Market Defined and What Are Its Core Parameters?#_x000D_

Virtual biopsy is a non-invasive diagnostic technique that uses advanced imaging technologies combined with computer algorithms to analyze tissues for signs of disease. Its primary purpose is to detect abnormalities, such as tumors or infections, without the need for a traditional tissue sample, reducing risks and recovery time for patients. This method is safer, faster, and less painful than traditional biopsies._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24424_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

#What is the Projected CAGR for the Virtual Biopsy Market Size from 2025 to 2034?#_x000D_

The online biopsy market has been expanding at an accelerated pace in recent times. Its projection indicates a growth from $0.63 billion in 2024 to $0.71 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 12.2%. Factors contributing to this growth during the historical period include a surge in demand for non-invasive diagnostic procedures, an uptick in early detection of diseases, amplified efficiency in medical imaging technology, enhanced convenience and comfort for patients, and a greater accessibility of telehealth services._x000D_

_x000D_

The market size for virtual biopsy is predicted to experience significant expansion in the upcoming years. By 2029, it’s anticipated to reach a value of $1.12 billion, with a compound annual growth rate (CAGR) of 12.0%. This growth during the forecast period could be linked to the increasing emphasis on economical healthcare solutions and preventive healthcare methods. Other contributing factors could include a heightened demand for personalized medicine, an escalating need for less invasive cancer therapies, and the escalating significance of precision oncology. Noteworthy trends during this forecast period could entail the development of imaging sensors and multimodal biopsy methods, incorporation of robotics for accuracy, innovation in the detection of non-invasive biomarkers, and amalgamation with 3D visualization tools._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Virtual Biopsy Market?#_x000D_

The virtual biopsy market is poised for growth, primarily driven by the increasing incidence of oncological disorders. These disorders, related to cancer, are characterized by abnormal cell growth and spread within the body. Factors such as unhealthy diet, sedentary lifestyle, tobacco consumption, and escalating exposure to environmental pollutants contribute to the rising prevalence of these conditions. Virtual biopsies offer a significant benefit by delivering non-invasive, real-time images that mitigate the need for conventional tissue biopsies, thereby enhancing diagnostic precision and patient safety. For example, as per the Australian Institute of Health and Welfare, a governmental institution in Australia, the total number of cancer diagnoses saw an uptick, reaching 160,570 in 2022 from 156,781 in 2021 – a surge of 3,789 cases. Hence, the climbing incidence of oncological disorders is fuelling the expansion of the virtual biopsy market._x000D_

_x000D_

#Which Primary Segments of the Virtual Biopsy Market Are Driving Growth and Industry Transformations?#_x000D_

The virtual biopsy market covered in this report is segmented –_x000D_

_x000D_

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas_x000D_

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds_x000D_

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies_x000D_

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers_x000D_

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions_x000D_

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions_x000D_

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders_x000D_

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions_x000D_

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions_x000D_

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the Virtual Biopsy Market?#_x000D_

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Virtual Biopsy Industry Dynamics?#_x000D_

Leading businesses in the virtual biopsy market are prioritizing the development and approval of technologically superior solutions, like the Magnetic Resonance Spectroscopy (MRS) platform. This non-invasive imaging technique provides detailed molecular data of tissues, improving diagnostic precision and real-time analysis for early illness identification and personalized care. For example, BrainSpec Inc., an American healthcare technology firm, gained the approval of the U.S. Food and Drug Administration (FDA) in November 2023 for its AI-powered BrainSpec platform. The device uses AI to analyze MR spectroscopy data, measuring brain metabolites such as 2-hydroxyglutarate, offering non-invasive virtual biopsies for diagnosing gliomas, alzheimer’s and multiple sclerosis. This system smoothly works with standard MRI scanners, automates data processing and delivers insights quickly, using a reference database of brain chemistry to enhance its diagnostic accuracy._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Virtual Biopsy Market?#_x000D_

Virtual biopsy is a non-invasive diagnostic technique that uses advanced imaging technologies combined with computer algorithms to analyze tissues for signs of disease. Its primary purpose is to detect abnormalities, such as tumors or infections, without the need for a traditional tissue sample, reducing risks and recovery time for patients. This method is safer, faster, and less painful than traditional biopsies._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model